(Q74329812)
Statements
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks (English)
L L Siu
A M Oza
E A Eisenhauer
P S Firby
J J Thiessen
M Michael
N Wainman
J Manzo
R Feld
R A Goldberg